Printer Friendly

BRISTOL-MYERS SQUIBB ANNOUNCES ACQUISITION OF LABORATORI GUIEU

 NEW YORK, Jan. 12 /PRNewswire/ -- Bristol-Myers Squibb Company (NYSE: BMY) today announced the acquisition of Laboratori Guieu, SpA, a leading Italian OTC skin products company, for an undisclosed amount.
 Headquartered in Milan, Laboratori Guieu manufactures and markets products for intimate skin cleansing needs and for pediatric skin care. It is best known for the Saugella and Babygella product lines. The company, which is privately held, has been family operated since it was founded in 1901.
 Bristol-Myers Squibb is a diversified, research-based health care company whose principal businesses are pharmaceuticals, consumer products, nutritionals and medical devices.
 -0- 1/12/93
 /CONTACT: Jon Weisberg of Bristol-Myers Squibb, 212-546-4343/
 (BMY)


CO: Bristol-Myers Squibb Company ST: New York IN: MTC SU: TNM

KD -- NY122 -- 4224 01/12/93 17:35 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jan 12, 1993
Words:127
Previous Article:BRISTOL-MYERS SQUIBB NAMES CHARLES G. THARP SENIOR VICE PRESIDENT OF HUMAN RESOURCES
Next Article:RICHARDSON ELECTRONICS, LTD. ANNOUNCES THIRD QUARTER DIVIDEND
Topics:


Related Articles
BRISTOL-MYERS SQUIBB NAMES RICHARD H. MALYAN SENIOR VICE PRESIDENT, INTERNATIONAL BUSINESS DEVELOPMENT
BRISTOL-MYERS SQUIBB COMPANY REPORTS SALES AND EARNINGS FOR THIRD QUARTER AND NINE MONTHS
BRISTOL-MYERS SQUIBB ACQUIRES THE UPSA GROUP, RESEARCH-BASED PHARMACEUTICAL COMPANY WITH $350MM SALES IN 84 COUNTRIES
BRISTOL-MYERS SQUIBB TO ACQUIRE CALGON VESTAL LABORATORIES FROM MERCK
BRISTOL-MYERS SQUIBB ACQUIRES CALGON VESTAL LABORATORIES
BRISTOL-MYERS SQUIBB TO ACQUIRE HUNGARIAN HEALTH CARE COMPANY
BRISTOL-MYERS SQUIBB ACQUIRES ARGENTINE PHARMACEUTICAL COMPANY
Bristol-Myers Squibb to Acquire Oncology Therapeutics Network; Leading U.S. Distributor of Products and Services to Office-Based Oncologists
Bristol-Myers Squibb to Seek Buyer for Its Infection Control and Contamination Control Businesses
Bristol-Myers Squibb Offers $350 Million In Debentures

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters